Publications by authors named "Chloe Rackham"

Claim this Profile
C
Characterisation of human pancreatic mesenchymal stromal cells in type 1 diabetes.
Rebecca E Dewhurst-Trigg, Jocelyn Atkins, Noel G Morgan, Martin Eichmann, Sarah J Richardson, Chloe L Rackham

Diabetologia· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal stromal cells and their secretory products reduce the inflammatory crosstalk between islets and endothelial cells.
Rebecca Dewhurst-Trigg, Jessica Hopkinson, Sarah Richardson, Peter Jones, Chloe Rackham

Endocrine· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal stromal cell secretory molecules improve the functional survival of human islets.
Tzu-Wen Hong, Sara Caxaria, Lydia F Daniels Gatward, Sufyan Hussain, Min Zhao, Chloe L Rackham

Diabet Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Ductal Ngn3-expressing progenitors contribute to adult β cell neogenesis in the pancreas.
Christopher Gribben, Christopher Lambert, Hendrik A Messal, Ella-Louise Hubber, Chloe Rackham

Cell Stem Cell· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Ductal Ngn3-expressing progenitors contribute to adult β cell neogenesis in the pancreas.
Christopher Gribben, Christopher Lambert, Hendrik A Messal, Ella-Louise Hubber, Chloe Rackham

Cell Stem Cell· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protecting islet functional viability using mesenchymal stromal cells.
Ella L Hubber, Chloe L Rackham, Peter M Jones

Stem Cells Transl Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Islet Transplantation Outcome in Mice.
Aileen J F King, Chloe L Rackham

Methods Mol Biol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing beta cell function through mesenchymal stromal cell-mediated mitochondria transfer.
Chloe L Rackham, Ella L Hubber, Anna Czajka, Afshan N Malik, Aileen J F King

Stem Cells· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the Effects of Mesenchymal Stromal Cells on Mouse and Human Islet Function.
Ahmed A Arzouni, Andreia Vargas-Seymour, Paramjeet K Dhadda, Chloe L Rackham, Guo-Cai Huang

Stem Cells Transl Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential of mesenchymal stromal cells for improving islet transplantation outcomes.
Chloe L Rackham, Peter M Jones

Curr Opin Pharmacol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal stromal cell secretory factors induce sustained improvements in islet function pre- and post-transplantation.
Chloe L Rackham, Stefan Amisten, Shanta J Persaud, Aileen J F King, Peter M Jones

Cytotherapy· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Composite Mesenchymal Stromal Cell Islets: Implications for Transplantation via the Clinically Preferred Intraportal Route.
Chloe L Rackham, Paramjeet K Dhadda, Sian J S Simpson, Mahdieh Godazgar, Aileen J F King

Transplant Direct· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal stromal cells improve human islet function through released products and extracellular matrix.
Ahmed A Arzouni, Andreia Vargas-Seymour, Chloe L Rackham, Paramjeet Dhadda, Guo-Cai Huang

Clin Sci (Lond)· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Annexin A1 Is a Key Modulator of Mesenchymal Stromal Cell-Mediated Improvements in Islet Function.
Chloe L Rackham, Andreia E Vargas, Ross G Hawkes, Stefan Amisten, Shanta J Persaud

Diabetes· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transitional-2 B cells acquire regulatory function during tolerance induction and contribute to allograft survival.
Aurélie Moreau, Paul A Blair, Jian-Guo Chai, Kulachelvy Ratnasothy, Emilie Stolarczyk, Chloe L Rackham

Eur J Immunol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preculturing Islets With Adipose-Derived Mesenchymal Stromal Cells Is an Effective Strategy for Improving Transplantation Efficiency at the Clinically Preferred Intraportal Site.
Chloe L Rackham, Paramjeet K Dhadda, Aurélie M Le Lay, Aileen J F King, Peter M Jones

Cell Med· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance of islet morphology is beneficial for transplantation outcome in diabetic mice.
Chloe L Rackham, Peter M Jones, Aileen J F King

PLoS One· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-culturing islets with mesenchymal stromal cells using a direct contact configuration is beneficial for transplantation outcome in diabetic mice.
Chloe Louise Rackham, Paramjeet Kaur Dhadda, Pedro Cesar Chagastelles, Sian Jazmine Shakara Simpson, Anshi Anjili Dattani

Cytotherapy· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex capture.
Jennifer S Allen, Karl Pang, Ania Skowera, Richard Ellis, Chloe Rackham

Diabetes· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.
Ania Skowera, Richard J Ellis, Ruben Varela-Calviño, Sefina Arif, Guo Cai Huang, Chloe Rackham

J Clin Invest· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis